183 related articles for article (PubMed ID: 32561910)
1. Steatohepatitis-Like Changes in Hepatocellular Adenoma.
Liu Y; Zen Y; Yeh MM
Am J Clin Pathol; 2020 Sep; 154(4):525-532. PubMed ID: 32561910
[TBL] [Abstract][Full Text] [Related]
2. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
[TBL] [Abstract][Full Text] [Related]
3. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
10. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population.
Liu HP; Zhao Q; Jin GZ; Qian YW; Gu YJ; Dong H; Lu XY; Cong WM; Wu MC
Pathol Res Pract; 2015 Dec; 211(12):918-24. PubMed ID: 26608415
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
12. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
15.
Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
[TBL] [Abstract][Full Text] [Related]
16. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH.
Oliveira S; Samba AK; Towbin AJ; Gupta A; Geller JI; Nathan JD; Kohli R
Pediatr Obes; 2018 Jan; 13(1):70-73. PubMed ID: 27780309
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
Jiao J; Finberg KE; Jain D; Morotti R
Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
[TBL] [Abstract][Full Text] [Related]
18. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
Salomao M; Remotti H; Vaughan R; Siegel AB; Lefkowitch JH; Moreira RK
Hum Pathol; 2012 May; 43(5):737-46. PubMed ID: 22018903
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenoma: An unsolved diagnostic enigma.
Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
